GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FutureChem Co Ltd (XKRX:220100) » Definitions » Institutional Ownership

FutureChem Co (XKRX:220100) Institutional Ownership : 3.57% (As of Mar. 28, 2025)


View and export this data going back to 2015. Start your Free Trial

What is FutureChem Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, FutureChem Co's institutional ownership is 3.57%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, FutureChem Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, FutureChem Co's Float Percentage Of Total Shares Outstanding is 0.00%.


FutureChem Co Institutional Ownership Historical Data

The historical data trend for FutureChem Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FutureChem Co Institutional Ownership Chart

FutureChem Co Historical Data

The historical data trend for FutureChem Co can be seen below:

2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28
Institutional Ownership 4.59 5.90 4.64 4.66 4.70 4.30 4.41 3.96 3.57 3.57

FutureChem Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


FutureChem Co Business Description

Traded in Other Exchanges
N/A
Address
2Floor, 21, Yeonmujang 3-gil, Seongdong-gu, Seoul, KOR, 04782
FutureChem Co Ltd is a radiopharmaceuticals company engaged in manufacturing related precursors chemicals, automatic synthesizer, and synthesis reagents and develops & commercializes new traces with research and development. It offers radiopharmaceuticals for diagnosing cancers, and Alzheimer's diseases; and automation modules and disposable goods, such as disposable cassettes, reagent kits, and radio-caps. It also provides peptide-based radiopharmaceuticals for radio-metal chelation and click reaction; linkers for bio-conjugation using copper-free/mediated click reaction. In addition, the company is involved in the research and development of radioisotope labeling technology; and automation devices. Further, it offers amino acids and reagents for peptides; and ionic liquids.

FutureChem Co Headlines

No Headlines